Skip to main content
Log in

Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?

  • Review Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Hypertension is a very common disease, and office measurements of blood pressure are frequently inaccurate. Ambulatory Blood Pressure Monitoring (ABPM) offers a more accurate diagnosis, more detailed readings of average blood pressures, better blood pressure measurement during sleep, fewer false positives by detecting more white-coat hypertension, and fewer false negatives by detecting more masked hypertension. ABPM offers better management of clinical outcomes. For example, based on more accurate measurements of blood pressure variability, ABPM demonstrates that taking antihypertensive medication at night leads to better controlled nocturnal blood pressure, which translates into less end organ damage and fewer clinical complications of hypertension. For these reasons, albeit some shortcomings which were discussed, ABPM should be considered as a first-line tool for diagnosing and managing hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.

    Article  PubMed  Google Scholar 

  2. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52(5):818–27.

    Article  CAS  PubMed  Google Scholar 

  3. Turner JR, Viera AJ, Shimbo D. Ambulatory blood pressure monitoring in clinical practice: a review. Am J Med. 2015;128(1):14–20.

    Article  PubMed  Google Scholar 

  4. Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30(7):1289–99.

    Article  CAS  PubMed  Google Scholar 

  5. Head GA. Ambulatory blood pressure monitoring is ready to replace clinic blood pressure in the diagnosis of hypertension: pro side of the argument. Hypertension. 2014;64(6):1175–81 discussion 81.

    Article  CAS  PubMed  Google Scholar 

  6. Redon J, Lurbe E. Ambulatory blood pressure monitoring is ready to replace clinic blood pressure in the diagnosis of hypertension: con side of the argument. Hypertension. 2014;64(6):1169–74 discussion 74.

    Article  CAS  PubMed  Google Scholar 

  7. Franklin SS, Thijs L, Hansen TW, O’Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62(6):982–7.

    Article  CAS  PubMed  Google Scholar 

  8. Ogedegbe G. Labeling and hypertension: it is time to intervene on its negative consequences. Hypertension. 2010;56(3):344–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. National Institute for Health and Care Excellence. Clinical guideline 127. Hypertension: clinical management of primary hypertension in adults. 2011 [09/05/2015]. http://guidance.nice.org.uk/CG127/Guidance

  10. Hermida RC, Smolensky MH, Ayala DE, Portaluppi F. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30(3):355–410.

    Article  CAS  PubMed  Google Scholar 

  11. Terawaki H, Metoki H, Nakayama M, Ohkubo T, Kikuya M, Asayama K, et al. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study. Hypertens Res. 2008;31(12):2129–35.

    Article  PubMed  Google Scholar 

  12. Hermida RC, Ayala DE, Smolensky MH, Fernandez JR, Mojon A, Crespo JJ, et al. Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders. Curr Hypertens Rep. 2014;16(2):412.

    Article  PubMed  Google Scholar 

  13. Kanbay M, Turkmen K, Ecder T, Covic A. Ambulatory blood pressure monitoring: from old concepts to novel insights. Int Urol Nephrol. 2012;44(1):173–82.

    Article  PubMed  Google Scholar 

  14. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57(5):898–902.

    Article  PubMed  Google Scholar 

  15. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, Deeks JJ, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259(2):225–8.

    Article  CAS  PubMed  Google Scholar 

  17. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68.

    PubMed  Google Scholar 

  18. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193–8.

    Article  CAS  PubMed  Google Scholar 

  19. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54(2):226–32.

    Article  CAS  PubMed  Google Scholar 

  20. Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med. 2005;165(13):1541–6.

    Article  PubMed  Google Scholar 

  21. Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens. 2005;18(6):772–8.

    Article  PubMed  Google Scholar 

  22. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40(6):795–6.

    Article  CAS  PubMed  Google Scholar 

  23. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24(1):52–8.

    Article  PubMed  Google Scholar 

  24. Franklin SS, O’Brien E, Thijs L, Asayama K, Staessen JA. Masked hypertension: a phenomenon of measurement. Hypertension. 2015;65(1):16–20.

    Article  CAS  PubMed  Google Scholar 

  25. Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28(10):2036–45.

    Article  CAS  PubMed  Google Scholar 

  26. Hansen TW, Kikuya M, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. J Hypertens. 2007;25(8):1554–64.

    Article  CAS  PubMed  Google Scholar 

  27. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111(14):1777–83.

    Article  PubMed  Google Scholar 

  28. Niiranen TJ, Maki J, Puukka P, Karanko H, Jula AM. Office, home, and ambulatory blood pressures as predictors of cardiovascular risk. Hypertension. 2014;64(2):281–6.

    Article  CAS  PubMed  Google Scholar 

  29. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348(24):2407–15.

    Article  PubMed  Google Scholar 

  30. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370(9594):1219–29.

    Article  PubMed  Google Scholar 

  31. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension. 2007;49(6):1235–41.

    Article  CAS  PubMed  Google Scholar 

  32. Kanbay M, Turgut F, Uyar ME, Akcay A, Covic A. Causes and mechanisms of nondipping hypertension. Clin Exp Hypertens. 2008;30(7):585–97.

    Article  PubMed  Google Scholar 

  33. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006;47(2):149–54.

    Article  CAS  PubMed  Google Scholar 

  34. Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 2006;295(24):2859–66.

    Article  CAS  PubMed  Google Scholar 

  35. Kario K. Prognosis in relation to blood pressure variability: pro side of the argument. Hypertension. 2015;65(6):1163–9.

    Article  CAS  PubMed  Google Scholar 

  36. Tai C, Sun Y, Dai N, Xu D, Chen W, Wang J, et al. Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77,299 patients. J Clin Hypertens (Greenwich). 2015;17(2):107–15.

    Article  Google Scholar 

  37. Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens. 2003;16(6):434–8.

    Article  PubMed  Google Scholar 

  38. Conway KS, Forbang N, Beben T, Criqui MH, Ix JH, Rifkin DE. Relationship between 24-hour ambulatory blood pressure and cognitive function in community-living older adults: The UCSD Ambulatory Blood Pressure Study. Am J Hypertens. 2015.

  39. Takeda N, Maemura K. Circadian clock and cardiovascular disease. J Cardiol. 2011;57(3):249–56.

    Article  PubMed  Google Scholar 

  40. Takeda N, Maemura K. Cardiovascular disease, chronopharmacotherapy, and the molecular clock. Adv Drug Deliv Rev. 2010;62(9–10):956–66.

    Article  CAS  PubMed  Google Scholar 

  41. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27(8):1629–51.

    Article  PubMed  Google Scholar 

  42. Liu X, Huang W, Leo S, Li Y, Liu M, Yuan H. Evening -versus morning- dosing drug therapy for chronic kidney disease patients with hypertension: a systematic review. Kidney Blood Press Res. 2014;39(5):427–40.

    Article  CAS  PubMed  Google Scholar 

  43. Kasiakogias A, Tsioufis C, Thomopoulos C, Andrikou I, Aragiannis D, Dimitriadis K, et al. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. J Hypertens. 2015;33(2):393–400.

    Article  CAS  PubMed  Google Scholar 

  44. Minutolo R, Borrelli S, Scigliano R, Bellizzi V, Chiodini P, Cianciaruso B, et al. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease. Nephrol Dial Transplant. 2007;22(8):2217–23.

    Article  PubMed  Google Scholar 

  45. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171(12):1090–8.

    Article  PubMed  Google Scholar 

  46. Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension. 2010;55(3):762–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Roberts MA, Pilmore HL, Tonkin AM, Garg AX, Pascoe EM, Badve SV, et al. Challenges in blood pressure measurement in patients treated with maintenance hemodialysis. Am J Kidney Dis. 2012;60(3):463–72.

    Article  PubMed  Google Scholar 

  48. Yarows SA, Khoury S, Sowers JR. Cost effectiveness of 24-hour ambulatory blood pressure monitoring in evaluation and treatment of essential hypertension. Am J Hypertens. 1994;7(5):464–8.

    CAS  PubMed  Google Scholar 

  49. Pessanha P, Viana M, Ferreira P, Bertoquini S, Polonia J. Diagnostic value and cost-benefit analysis of 24 hours ambulatory blood pressure monitoring in primary care in Portugal. BMC Cardiovasc Disord. 2013;13:57.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378(9798):1219–30.

    Article  PubMed  Google Scholar 

  51. Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ. Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels. J Trauma. 1997;42(6):997–1004 discussion -5.

    Article  CAS  PubMed  Google Scholar 

  52. Ambulatory blood pressure monitoring. Aust Fam Physician. 2011;40(11):877–80.

    Google Scholar 

  53. Campbell NR, Hemmelgarn BR. New recommendations for the use of ambulatory blood pressure monitoring in the diagnosis of hypertension. CMAJ. 2012;184(6):633–4.

    Article  PubMed Central  PubMed  Google Scholar 

  54. Japanese Circulation Society Joint Working Group. Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest version. Circ J. 2012;76:508–19.

    Article  Google Scholar 

  55. Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115(4):291–7.

    Article  PubMed  Google Scholar 

  56. Kaplan NM. Resistant hypertension. J Hypertens. 2005;23(8):1441–4.

    Article  CAS  PubMed  Google Scholar 

  57. Portaluppi F, Montanari L, Massari M, Di Chiara V, Capanna M. Loss of nocturnal decline of blood pressure in hypertension due to chronic renal failure. Am J Hypertens. 1991;4(1 Pt 1):20–6.

    CAS  PubMed  Google Scholar 

  58. Mizuno M, Fukuda M, Miura T, Wakamatsu T, Naito T, Sato R, et al. Morning hypertension in chronic kidney disease is sustained type, but not surge type. Blood Press Monit. 2012;17(1):20–3.

    Article  PubMed  Google Scholar 

  59. Cohen DL, Huan Y, Townsend RR. Ambulatory blood pressure in chronic kidney disease. Curr Hypertens Rep. 2013;15(3):160–6.

    Article  PubMed  Google Scholar 

  60. Agarwal R. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol: CJASN. 2009;4(4):830–7.

    Article  PubMed Central  PubMed  Google Scholar 

  61. Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Kanbay.

Ethics declarations

Conflict of interest

Authors have no conflict of interest.

Financial support

None.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Solak, Y., Kario, K., Covic, A. et al. Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension?. Clin Exp Nephrol 20, 14–22 (2016). https://doi.org/10.1007/s10157-015-1184-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1184-1

Keywords

Navigation